Loading...

CMPS COMPASS PATHWAYS PLC Expansion Plans 8-K Filing

CMPS

CMPS

COMPASS PATHWAYS PLC

(CMPS)

2025 8-K

Financial Results Announced

Board Changes Announced

Financial Statements

Product Expansion

Financial Statements

Financial Results

Financial Results

Financial Results and Board...

AGM Voting Results

Financial Results Announcement

Positive Study Results

Resignations from Board of ...

Financial Results Announcement

Appointment of Chief Financ...

Financial Results Announcement

Departure of Chief Financia...

Appointment of Director

Private Placement

Financial Results Announcement

AGM Voting Results

Departure of Directors or C...

Financial Results Announcement

Corporate Presentation

Financial Results Announcement

Regulation FD Disclosure

External Links:

On June 23, 2025, COMPASS Pathways plc announced that their Phase 3 COMP005 trial for COMP360, a treatment for depression, successfully met its primary endpoint, showing a significant reduction in symptoms with a p-value of less than 0.001 and a treatment difference of -3.6 points compared to placebo.

AI Assistant

COMPASS PATHWAYS PLC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.